These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 8575754

  • 1. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
    Okuda T, Hirai H, Valentine VA, Shurtleff SA, Kidd VJ, Lahti JM, Sherr CJ, Downing JR.
    Genomics; 1995 Oct 10; 29(3):623-30. PubMed ID: 8575754
    [Abstract] [Full Text] [Related]

  • 2. Cloning and characterization of murine p16INK4a and p15INK4b genes.
    Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ, Serrano M.
    Oncogene; 1995 Aug 17; 11(4):635-45. PubMed ID: 7651726
    [Abstract] [Full Text] [Related]

  • 3. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J, Fried M.
    Oncogene; 2001 Nov 01; 20(50):7447-52. PubMed ID: 11704876
    [Abstract] [Full Text] [Related]

  • 4. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
    Zindy F, Soares H, Herzog KH, Morgan J, Sherr CJ, Roussel MF.
    Cell Growth Differ; 1997 Nov 01; 8(11):1139-50. PubMed ID: 9372237
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M.
    Clin Cancer Res; 1999 Jul 01; 5(7):1855-61. PubMed ID: 10430092
    [Abstract] [Full Text] [Related]

  • 8. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
    Suzuki T, Narita T, Uchida-Toita M, Yoshida M.
    Virology; 1999 Jul 05; 259(2):384-91. PubMed ID: 10388662
    [Abstract] [Full Text] [Related]

  • 10. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.
    Fink JR, LeBien TW.
    Exp Hematol; 2001 Apr 05; 29(4):490-8. PubMed ID: 11301189
    [Abstract] [Full Text] [Related]

  • 11. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
    Arcellana-Panlilio MY, Egeler RM, Ujack E, Magliocco A, Stuart GC, Robbins SM, Coppes MJ.
    Genes Chromosomes Cancer; 2002 Oct 05; 35(2):176-81. PubMed ID: 12203782
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M, Muller WJ, Singh G, Graham FL.
    Oncogene; 1999 Mar 04; 18(9):1663-76. PubMed ID: 10208428
    [Abstract] [Full Text] [Related]

  • 14. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
    Ohnishi H, Hanada R, Horibe K, Hongo T, Kawamura M, Naritaka S, Bessho F, Yanagisawa M, Nobori T, Yamamori S, Hayashi Y.
    Leukemia; 1996 Jul 04; 10(7):1104-10. PubMed ID: 8683987
    [Abstract] [Full Text] [Related]

  • 15. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
    Baumgartner R, Fernandez-Catalan C, Winoto A, Huber R, Engh RA, Holak TA.
    Structure; 1998 Oct 15; 6(10):1279-90. PubMed ID: 9782052
    [Abstract] [Full Text] [Related]

  • 16. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
    Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, Curcio-Brint AM, Liu Q, Pui CH, Sherr CJ.
    Blood; 1995 May 01; 85(9):2321-30. PubMed ID: 7727766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 19. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
    Delmer A, Tang R, Senamaud-Beaufort C, Paterlini P, Brechot C, Zittoun R.
    Leukemia; 1995 Jul 20; 9(7):1240-5. PubMed ID: 7630199
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.